Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05897723 · ClinicalTrials.gov registry record · NA

Fractional Radiofrequency for Reduction of Surgical Scar Formation

A NA study of Surgical Incision, sponsored by Venus Concept.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05897723 is a NA study of Surgical Incision that is actively recruiting participants, run by Venus Concept. The registered enrollment target is 20 participants, below the 157-participant average among 3 other Surgical Incision trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05897723, a NA study of Surgical Incision, is actively recruiting participants, sponsored by Venus Concept.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Safety and Efficacy of Fractional Radiofrequency for the Reduction of Surgical Scar Formation

Conditions Studied

Interventions

  • DEVICE Fractional Radiofrequency

Study Locations (1)

Texas

  • UT Southwestern Medical Center, Department of Plastic Surgery - Dallas

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-09-01
Est. Completion 2025-12-31
Phase NA

Sponsor

Venus Concept

22 total trials

What the Registry Record Tells You About NCT05897723

The ClinicalTrials.gov registry entry for NCT05897723 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 157-participant average among 3 other Surgical Incision trials with a reported enrollment target (87% lower). The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgical Incision appearing as the primary indexed condition, and to 1 intervention - of which Fractional Radiofrequency is the first listed.

NCT05897723 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05897723 about?

NCT05897723 is a clinical study titled "Fractional Radiofrequency for Reduction of Surgical Scar Formation". Safety and Efficacy of Fractional Radiofrequency for the Reduction of Surgical Scar Formation

What is the current status of trial NCT05897723?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-09-01. Estimated completion is 2025-12-31.

What conditions does trial NCT05897723 study?

This clinical trial studies the following conditions: Surgical Incision.

What interventions are being tested in trial NCT05897723?

The interventions under investigation include: Fractional Radiofrequency (DEVICE).

Who is sponsoring clinical trial NCT05897723?

This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05897723 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgical Incision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.